The Xerostomia Therapeutics Market was valued at USD 2.33 billion in 2024 and is projected to reach USD 3.51 billion by 2035, growing at a compound annual growth rate (CAGR) of approximately 3.81% from 2025 to 2035. This market focuses on developing treatments for dry mouth (xerostomia), a condition caused by decreased saliva production due to factors such as Sjogren’s syndrome, diabe... https://www.metatechinsights.com/industry-insights/xerostomia-therapeutics-market-2465